Discover how Zydus Wellness is reinventing Complan, the iconic health drink, by expanding its target audience, leveraging digital commerce, and strengthening its scientific credibility to stay ...

Brokerage firms remain divided on Zydus Lifesciences as the company announced to acquire France-based Amplitude Surgical for ...

Zydus Lifesciences on Tuesday said it has entered ... In Amplitude Surgical, we see several medium-term and long-term growth opportunities with respect to portfolio, capabilities, manufacturing ...

Zydus Lifesciences announced it is negotiating to acquire a majority stake in French medtech firm Amplitude Surgical for approximately Rs 2,500 crore. The acquisition aims to boost Zydus's global ...

Zydus Wellness Ltd (BOM:531335) reported a consolidated net sales growth of 12.7% year-on-year, with volume growth of 4.8%. The Personal Care segment achieved a remarkable double-digit growth of ...

Zydus Lifesciences announced today it will develop ... The development comes as childhood immunisation schedules grow increasingly crowded and expensive. According to WHO data, typhoid causes ...

New Delhi, Zydus Lifesciences Ltd on Friday reported over two-fold rise in consolidated net profit at Rs 1,086.9 crore for the first quarter ended June 30, 2023 driven by strong sales growth from ...

Zydus Lifesciences’ revenue was largely in ... domestic business is set to benefit from chronic therapy expansion and double-digit growth in Consumer Wellness with strategic acquisitions.

US formulation sales for Zydus were USD 285 million in 3Q FY25, up 29% YoY, higher than market estimated USD 270 million. The US market is a key growth driver for the company, accounting for ...

Spinal Cord Injury Therapeutics Market is estimated to be valued at US$ 7.4 billion in 2023 and is expected to exhibit a CAGR of 5.4% by (2023-2030). BURLINGAME, CA, UNITED STATES, February 11 ...